Discrepancies between subjective and objective cognition in persons with multiple sclerosis: Exploring the role of cannabis use.
Research examining cannabis cognitive effects in multiple sclerosis patients found that cannabis users report greater perceived cognitive deficits than non-users. This cross-sectional study of 847 MS patients provides important insights into the…
NfL and GFAP quantification and associations with mental health in recreational cannabis users-Results from the Swiss study on recreational cannabis access via pharmacies.
A Swiss study measuring cannabis brain damage biomarkers study results in 331 regular users found no evidence of nerve damage and unexpectedly lower levels of brain injury markers. These objective biomarker findings challenge assumptions about cannabis…
Randomised Controlled Trial Evidence on Medicinal Cannabis for Treatment of Mental Health and Substance Use Disorders: A Scoping Review.
A comprehensive scoping review of randomized controlled trials reveals limited high-quality medicinal cannabis mental health evidence for treating psychiatric and substance use disorders. The systematic review highlights significant gaps in rigorous…
Health-related quality of life in patients receiving medicinal cannabis: systematic review and meta-analysis of primary research findings 2015-2025.
A comprehensive systematic review and meta-analysis examining medicinal cannabis quality of life outcomes found consistent improvements across chronic conditions. The research analyzed validated HRQL measures from 2015-2025, showing benefits in short,…
Patient perspectives on non‑traumatic painful upper‑extremity conditions, co-occurring risky substance use, and an integrated web-based mind-body intervention addressing both conditions.
Recent qualitative research examining upper extremity pain and substance use management reveals patients commonly use alcohol, cannabis, and tobacco for symptom relief but lack awareness of pain-substance interactions. The study provides insights for…
Cognitive performance and subjective effects the morning after last use of smoked cannabis by adults who use cannabis frequently: An observational study.
A controlled observational study found no cognitive impairment in regular cannabis users 12-15 hours after smoking, with important implications for understanding cannabis cognitive effects next day. This research provides evidence that cognitive function…
Therapeutically Motivated Cannabis Use for Anxiety: Daily and Longitudinal Reductions Vary Between Flower and Edible Products.
This cannabis flower anxiety relief study found that flower products provide superior anxiety reduction compared to edibles. Therapeutically motivated users experienced different daily and longitudinal effects. Individual responses vary, highlighting the…
Randomized and Blind Evaluation of the Efficacy of a Full-Spectrum Oral Cannabis Extract
This randomized clinical trial demonstrates that full-spectrum cannabis osteoarthritis pain relief is significant compared to placebo. The study provides controlled evidence supporting cannabinoid analgesic effects in degenerative joint disease. These…
Reducing Severe Breathlessness with Dronabinol in Severe COPD Patients
A new randomized crossover trial will investigate whether dronabinol COPD breathlessness treatment can help patients with severe symptoms. This protocol review examines the study design and clinical context for cannabis medicine in respiratory care. The…
Analgesic Effect of Cannabinoids for Fibromyalgia: A Systematic Review and Meta-Analysis
This meta-analysis highlights cannabinoid analgesia fibromyalgia benefits with statistically significant pain reduction. Fibromyalgia patients often face inadequate relief from conventional therapies. Cannabinoid analgesia fibromyalgia offers a promising…